1216 CHAPTER 30 The Organic Chemistry of Drugshas the same imidazole ring as 4-methylhistidine, but it has a sulfur atom
and a functional group based on guanidine (Section 23.1). has a different het-
erocyclic ring, and although its side chain is similar to that of it does not
contain a guanidino group.
Observations that serotonin was implicated in the generation of migraine attacks
led to the development of drugs that bind to serotonin receptors. Sumatriptan, intro-
duced in 1991, relieved not only the pain associated with migraines, but also many of
migraine’s other symptoms, including sensitivity to light and sound and nausea.The success of sumatriptan spurred a search for other antimigraine agents by molecular
modification, and three new triptans were introduced in 1997 and 1998. These
second-generation triptans showed some improvements over sumatriptan—specifically,
a longer half-life, reduced cardiac side effects, and improved CNS penetration.In screening modified compounds, it is not unusual to find a compound with a com-
pletely different pharmacological activity than the lead compound. For example, a
molecular modification of a sulfonamide, an antibiotic, led to tolbutamide, a drug with
hypoglycemic activity (Section 25.8).a sulfonamideH 2 NNHRSOOSOOH 3 C NH C NHCH 2 CH 2 CH 2 CH 3OtolbutamideHOHNCH 2 CH 2 NH 2serotoninHNCH 2 CH 2 NCH 3CH 3sumatriptan
ImitrexCH 3 NH SOOTagamet®,Zantac®Tagamet®Tutorial:
Structural similarities in classes
of drugsNHCH 3 CH 2 SCH 2 CH 2 NH NHCH 3NN
HCH 2 CH 2 NH 3NO 2CH 3+++CN
CCHH
NC
CH 3 NHCH 2 OCH 34-methylhistaminecimetidine
Tagametranitidine
ZantacNN
HCH 2 SCH 2 CH 2 NHCH 3OO
HH NNCH 2 CH 2 NCH 3CH 3zolmitriptan
ZomigHNNCH 3naratriptan
AmergeHNNNCH 2 CH 2 NCH 3CH 3rizatriptan
MaxaltNCH 3 NH SOOBRUI30-1204_ 1228r2 18-03-2003 8:55 AM Page 1216